Recurrence of Vesico-ureteral Reflux in Children: is Still the Endoscopic Injection the Best Option?

Overview

Journal Transl Androl Urol

Date 2024 Sep 16

PMID 39280646

Authors

Francesca Nascimben

Isabelle Talon

Consuelo Maldonado

Rossella Angotti

Francesco Molinaro

Raphael Moog

Francois Becmeur

Affiliations

Soon will be listed here.

Abstract

Background: Endoscopic injection (EI) is a safe treatment for vesico-ureteral reflux (VUR) in children, but recurrences are not insignificant. This study aims to show if multiple EI is still the best first line management even if in case of recurrences.

Methods: All patients affected by primary VUR, treated with at least one EI and with at least 5 years follow up were included. All general data were analyzed. Recurrence rate after one, two and three EIs were calculated.

Results: One hundred and sixty-one patients (total number =210) were healed after 1 injection, 28 after 2 and 4 after 3 with a global success rate of 91.90%. Recurrence rate is higher in patients older than 3 years old and with IV and V reflux grade. Even if 67.7% of recurrent VUR after one injection was symptomatic, diagnosis of recurrences after multiple EI was mainly radiological. Only 8% of the patients underwent EI need an anti-reflux surgery.

Conclusions: Thanks to its low costs and the acceptable recurrence rate, Deflux EI should be proposed as the first therapeutic approach for children affected by VUR, especially in those with low and moderate grades of VUR. Multiple injections could be contraindicated only in older children thank 1 year with high-grade VUR (IV symptomatic and V grade).

References

Mattoo T, Shaikh N, Nelson C . Contemporary Management of Urinary Tract Infection in Children. Pediatrics. 2021; 147(2). DOI: 10.1542/peds.2020-012138. View

Dogan A, Ozkan K, Guler A, Karakaya A . Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: Comparison of Dexell and Vantris. Actas Urol Esp (Engl Ed). 2021; 45(8):545-551. DOI: 10.1016/j.acuroe.2021.07.002. View

Tessier B, Scalabre A, Harper L, Garnier S, Vermesch S, Lopez C . Comparative study of open, laparoscopic and endoscopic treatments of intermediate grade vesicoureteral reflux in children. Surg Endosc. 2022; 37(4):2682-2687. DOI: 10.1007/s00464-021-08985-y. View

Escolino M, Kalfa N, Castagnetti M, Caione P, Esposito G, Florio L . Endoscopic injection of bulking agents in pediatric vesicoureteral reflux: a narrative review of the literature. Pediatr Surg Int. 2023; 39(1):133. PMC: 9938816. DOI: 10.1007/s00383-023-05426-w. View

Homayoon K, Chen J, Cummings J, Steinhardt G . Voiding dysfunction: outcome in infants with congenital vesicoureteral reflux. Urology. 2005; 66(5):1091-4. DOI: 10.1016/j.urology.2005.05.053. View

Amiri R, Faradmal J, Rezaie B, Sedighi I, Sanaei Z, Solgi G . Evaluation of Urinary Neutrophil Gelatinase-associated Lipocalin as a Biomarker in Pediatric Vesicoureteral Reflux Assessment. Iran J Kidney Dis. 2020; 14(5):373-379. View

Elder J, Diaz M, Caldamone A, Cendron M, Greenfield S, Hurwitz R . Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol. 2006; 175(2):716-22. DOI: 10.1016/S0022-5347(05)00210-7. View

Bae Y, Park M, Oh M, Moon D . Endoscopic Subureteral Injection for the Treatment of Vesicoureteral Reflux in Children: Polydimethylsiloxane (Macroplastique(R)) versus Dextranomer/Hyaluronic Acid Copolymer (Deflux(R)). Korean J Urol. 2010; 51(2):128-31. PMC: 2855475. DOI: 10.4111/kju.2010.51.2.128. View

Anand S, Bajpai M, Khanna T, Kumar A . Urinary biomarkers as point-of-care tests for predicting progressive deterioration of kidney function in congenital anomalies of kidney and urinary tract: trefoil family factors (TFFs) as the emerging biomarkers. Pediatr Nephrol. 2021; 36(6):1465-1472. DOI: 10.1007/s00467-020-04841-8. View

10.

Kobelt G, Canning D, Hensle T, Lackgren G . The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol. 2003; 169(4):1480-4; discdussion 1484-5. DOI: 10.1097/01.ju.0000056638.75652.54. View

11.

Biocic M, Todoric J, Budimir D, Cvitkovic Roic A, Pogorelic Z, Juric I . Endoscopic treatment of vesicoureteral reflux in children with subureteral dextranomer/hyaluronic acid injection: a single-centre, 7-year experience. Can J Surg. 2012; 55(5):301-6. PMC: 3468641. DOI: 10.1503/cjs.003411. View

12.

Nordenstrom J, Holmdahl G, Brandstrom P, Sixt R, Stokland E, Sillen U . The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome. J Pediatr Urol. 2016; 13(2):130-138. DOI: 10.1016/j.jpurol.2016.08.026. View

13.

Chung P, Lan L, Wong K, Tam P . Deflux injection for the treatment of vesicoureteric reflux in children--a single centre's experience. Asian J Surg. 2009; 32(3):163-6. DOI: 10.1016/S1015-9584(09)60388-2. View

14.

Wheeler D, Vimalachandra D, Hodson E, ROY L, Smith G, Craig J . Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child. 2003; 88(8):688-94. PMC: 1719586. DOI: 10.1136/adc.88.8.688. View

15.

ODonnell B, Puri P . Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed). 1984; 289(6436):7-9. PMC: 1442065. DOI: 10.1136/bmj.289.6436.7. View

16.

Kocherov S, Ulman I, Nikolaev S, Corbetta J, Rudin Y, Slavkovic A . Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris). Urology. 2014; 84(3):689-93. DOI: 10.1016/j.urology.2014.04.033. View

17.

Esposito C, Yamataka A, Varlet F, Castagnetti M, Scalabre A, Fourcade L . Current trends in 2021 in surgical management of vesico-ureteral reflux in pediatric patients: results of a multicenter international survey on 552 patients. Minerva Urol Nephrol. 2021; 75(1):106-115. DOI: 10.23736/S2724-6051.21.04430-X. View

18.

Kirsch A, Arlen A, Lackgren G . Current trends in dextranomer hyaluronic acid copolymer (Deflux) injection technique for endoscopic treatment of vesicoureteral reflux. Urology. 2014; 84(2):462-8. DOI: 10.1016/j.urology.2014.04.032. View

19.

Sorensen M, Koyle M, Cowan C, Zamilpa I, Shnorhavorian M, Lendvay T . Injection volumes of dextranomer/hyaluronic acid are increasing in the endoscopic management of vesicoureteral reflux. Pediatr Surg Int. 2010; 26(5):509-13. DOI: 10.1007/s00383-010-2558-9. View

20.

Ormaechea M, Ruiz E, Denes E, Gimenez F, Denes F, Moldes J . New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children. J Urol. 2009; 183(2):714-7. DOI: 10.1016/j.juro.2009.10.047. View